These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25398459)

  • 1. Transcriptional changes that characterize the immune reactions of leprosy.
    Dupnik KM; Bair TB; Maia AO; Amorim FM; Costa MR; Keesen TS; Valverde JG; Queiroz Mdo C; Medeiros LL; de Lucena NL; Wilson ME; Nobre ML; Johnson WD; Jeronimo SM
    J Infect Dis; 2015 May; 211(10):1658-76. PubMed ID: 25398459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole blood profiling of leprosy type 1(reversal) reactions highlights prominence of innate immune response genes.
    Rêgo JL; de Lima Santana N; Machado PRL; Ribeiro-Alves M; de Toledo-Pinto TG; Castellucci LC; Moraes MO
    BMC Infect Dis; 2018 Aug; 18(1):422. PubMed ID: 30143000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL).
    Moraes MO; Sarno EN; Almeida AS; Saraiva BC; Nery JA; Martins RC; Sampaio EP
    Scand J Immunol; 1999 Nov; 50(5):541-9. PubMed ID: 10564558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C1q expression in Erythema nodosum leprosum.
    Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
    Teles RM; Teles RB; Amadeu TP; Moura DF; Mendonça-Lima L; Ferreira H; Santos IM; Nery JA; Sarno EN; Sampaio EP
    Infect Immun; 2010 Mar; 78(3):1012-21. PubMed ID: 20008541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.
    Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK
    PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Pentraxin-3 Concentrations in Patients With Leprosy: Potential Biomarker of Erythema Nodosum Leprosum.
    Mendes MA; de Carvalho DS; Amadeu TP; Silva BJA; Prata RBDS; da Silva CO; Ferreira H; Hacker MA; Nery JAC; Pinheiro RO; Sampaio EP; Sarno EN; Schmitz V
    J Infect Dis; 2017 Dec; 216(12):1635-1643. PubMed ID: 29272525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Sensing via TLR-9 Constitutes a Major Innate Immunity Pathway Activated during Erythema Nodosum Leprosum.
    Dias AA; Silva CO; Santos JP; Batista-Silva LR; Acosta CC; Fontes AN; Pinheiro RO; Lara FA; Machado AM; Nery JA; Sarno EN; Pereira GM; Pessolani MC
    J Immunol; 2016 Sep; 197(5):1905-13. PubMed ID: 27474073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T regulatory cells and plasmocytoid dentritic cells in hansen disease: a new insight into pathogenesis?
    Massone C; Nunzi E; Ribeiro-Rodrigues R; Talhari C; Talhari S; Schettini APM; Parente JNT; Brunasso AM; Puntoni M; Clapasson A; Noto S; Cerroni L
    Am J Dermatopathol; 2010 May; 32(3):251-256. PubMed ID: 20075708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy.
    Saini C; Prasad HK; Rani R; Murtaza A; Misra N; Shanker Narayan NP; Nath I
    Clin Vaccine Immunol; 2013 May; 20(5):673-82. PubMed ID: 23446220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
    Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
    Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states.
    Santos DO; Castro HC; Bourguignon SC; Bastos OM; Rodrigues CR; Van Heuverswyn H; Nery JA; Miranda A
    Clin Exp Dermatol; 2007 Jan; 32(1):75-80. PubMed ID: 17305909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.
    Iyer A; Hatta M; Usman R; Luiten S; Oskam L; Faber W; Geluk A; Das P
    Clin Exp Immunol; 2007 Nov; 150(2):210-6. PubMed ID: 17937676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.